Krystal Biotech up on smaller-than-expected Q3 loss

Krystal Biotech

07/11/2022 17:09

** Shares of drug developer Krystal Biotech Inc  KRYS.O 
rise 3.5% to $75.8
    ** Co reports Q3 diluted loss of $1.17 per share while
analysts' expected a loss of $1.22 per share - Refinitiv IBES 
    ** KRYS says its cash, cash equivalents, and investments
totaled $407.0 mln for the quarter
    ** Including session's gain, stock is up 8.4% YTD
 (Reporting by Pratik Jain)
 ((Pratik.Jain@thomsonreuters.com;))